SCHEMBL25358698

SCHEMBL25358698

CNC(CCc1ccc(OC)nc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 4/20 0.47
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
PKM P14618 1/20 0.45
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
NAMPT P43490 1/20 0.41
KLKB1 P03952 1/20 0.40
NNMT P40261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
PABPC1 P11940 1/20 0.39
TAS2R14 Q9NYV8 1/20 0.39
ACACA Q13085 1/20 0.39
ERCC5 P28715 1/20 0.39
GRN P28799 1/20 0.38
SORT1 Q99523 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29633826 1.00 ACACB (0.47) ACACBNPC1LMNAPKMKMT2A
SCHEMBL26008206 1.00 ACACB (0.47) ACACBNPC1LMNAPKMKMT2A
SCHEMBL26009193 0.89 ACACB (0.50) ACACBNPC1LMNAPKMKMT2A
SCHEMBL29633767 0.86 KLKB1 (0.48) ACACBNPC1LMNAPKMKMT2A
SCHEMBL22444704 0.86 KLKB1 (0.48) ACACBNPC1LMNAPKMKMT2A
SCHEMBL25356796 0.86 KLKB1 (0.48) ACACBNPC1LMNAPKMKMT2A
SCHEMBL26014479 0.84 PPARG (0.40) ACACBNPC1LMNAPKMACACA
SCHEMBL25178744 0.81 ACACB (0.46) ACACBNPC1LMNAPKMKMT2A
SCHEMBL22444690 0.81 ACACB (0.46) ACACBNPC1LMNAPKMKMT2A
SCHEMBL30510332 0.81 ACACB (0.46) ACACBNPC1LMNAPKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US claimed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP ACACB 3885/4885NPC1 3981/4885LMNA 3240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.